Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cardiac Health and Mental Health, and Cardiac Imaging and Diagnostics.
The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050
<b>AHA PREVENT Equations and Lipoprotein(a) for Cardiovascular Disease Risk </b>
Upfront lipid-lowering combination therapy in high cardiovascular risk patients: a route to effective atherosclerotic cardiovascular disease prevention
Allocation of Semaglutide According to Coronary Artery Calcium and BMI
The global cardiovascular–liver–metabolic syndemic: epidemiology, trends and challenges
Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease
Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States
Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)
Traditional risk factors, optimal cardiovascular health, and elevated lipoprotein(a)
Left Main Coronary Artery Calcium and Diabetes Confer Very-High-Risk Equivalence in Coronary Artery Calcium >1,000
Development and Validation of the American Heart Association’s PREVENT Equations
Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019
Acute Cardiac Events During COVID-19-Associated Hospitalizations
Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?
Demographic and regional trends of peripheral artery disease-related mortality in the United States, 2000 to 2019
High-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Risk Assessment: Exploring and Explaining the “U”-Shaped Curve
Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations
Health equity in the implementation of genomics and precision medicine: A public health imperative
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study
Evolving Role of Calcium Density in Coronary Artery Calcium Scoring and Atherosclerotic Cardiovascular Disease Risk
Statin therapy for the primary prevention of cardiovascular disease: Pros
Cardiac Rehabilitation and the COVID-19 Pandemic: Persistent Declines in Cardiac Rehabilitation Participation and Access Among US Medicare Beneficiaries
Statin associated muscle symptoms: An update and review
Coronary Artery Calcium for Risk Stratification of Sudden Cardiac Death
U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women